Soluble PD-1 and PD-L1: Predictive and prognostic significance in cancer

258Citations
Citations of this article
263Readers
Mendeley users who have this article in their library.

Abstract

The membrane-bound molecules programmed death 1 (PD-1) and its ligand PD-L1 (PD-1/PD-L1) belong to the immune checkpoint pathway. PD-1 pathway downregulates effector T cells in immune response, thereby causing immune suppression. Recent studies have revealed that membrane-bound PD-1 and PD-L1 also have soluble forms. These soluble forms increase the complexity and diversity of the composition and function of the PD-1/PD-L1 signaling pathway. However, the exact roles of these molecules remain unknown. The objective of this systematic review was to elucidate the biological significance of soluble PD-1/PD-L1 in human cancers and evaluate whether they are potential diagnostic, therapeutic, or prognostic biomarkers. We expect to provide new clues for future research on soluble PD-1/PD-L1 pathway in human malignant tumors.

Cite

CITATION STYLE

APA

Zhu, X., & Lang, J. (2017). Soluble PD-1 and PD-L1: Predictive and prognostic significance in cancer. Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.18311

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free